Rituximab maintenance therapy in diffuse large B-cell lymphoma: Is XY the most important variable?

Research output: Contribution to journalEditorial

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)853-855
Number of pages3
JournalHaematologica
Volume100
Issue number7
DOIs
StatePublished - Jul 6 2015

Fingerprint

Drug Administration Schedule
Antineoplastic Combined Chemotherapy Protocols
Sex Factors
Lymphoma, Large B-Cell, Diffuse
Vincristine
Prednisone
Antineoplastic Agents
Doxorubicin
Cyclophosphamide
Therapeutics
Rituximab

ASJC Scopus subject areas

  • Hematology

Cite this

Rituximab maintenance therapy in diffuse large B-cell lymphoma : Is XY the most important variable? / Lunning, Matthew A; Armitage, James Olen.

In: Haematologica, Vol. 100, No. 7, 06.07.2015, p. 853-855.

Research output: Contribution to journalEditorial

@article{dc99b54f40d94c679eae5672c5c48da2,
title = "Rituximab maintenance therapy in diffuse large B-cell lymphoma: Is XY the most important variable?",
author = "Lunning, {Matthew A} and Armitage, {James Olen}",
year = "2015",
month = "7",
day = "6",
doi = "10.3324/haematol.2015.129924",
language = "English (US)",
volume = "100",
pages = "853--855",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "7",

}

TY - JOUR

T1 - Rituximab maintenance therapy in diffuse large B-cell lymphoma

T2 - Is XY the most important variable?

AU - Lunning, Matthew A

AU - Armitage, James Olen

PY - 2015/7/6

Y1 - 2015/7/6

UR - http://www.scopus.com/inward/record.url?scp=84936069220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936069220&partnerID=8YFLogxK

U2 - 10.3324/haematol.2015.129924

DO - 10.3324/haematol.2015.129924

M3 - Editorial

C2 - 26130511

AN - SCOPUS:84936069220

VL - 100

SP - 853

EP - 855

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 7

ER -